WHO'S Researchers are meeting later today to determine if this variant is of "Interest" or of "Concern" !. By the
end of the day, we shall know whether this is a dip to buy or a big pullback. It will take weeks for testing this
new strain, W/ such big M2 hard to crash !
end of the day, we shall know whether this is a dip to buy or a big pullback. It will take weeks for testing this
new strain, W/ such big M2 hard to crash !
تعليق:
50% Retracements since Covid's low is the most common bouncing area according to our studies !
I do more in depth studies of stocks on my twitter account. Hope you would enjoy it there as you are enjoying it here.
****** Past performance is no guarantee of future results***
twitter.com/samitrading1
****** Past performance is no guarantee of future results***
twitter.com/samitrading1
- The chief executive of drugmaker Moderna (NASDAQ:MRNA) set off fresh alarm bells in financial markets on Tuesday with a warning that existing COVID-19 vaccines would be less effective against the new Omicron variant than they have been against Delta.